Julvelin® Contraindications / Drug Interactions
Julvelin®

Julvelin® is an an oral therapy for the treatment of Diabetes mellitus type 2, antidiabetic, hypoglycemic.

 

Julvelin® Safety Information

Important Safety Information


Contraindications / Drug Interactions:

Berberine may counter or prevent irregular heartbeat. Caution is advised when taking berberine with other agents that alter heart rate.

Berberine may decrease the efficacy of tetracycline; in theory, berberine may decrease the efficacy of other agents with antibacterial activity.

Berberine bisulfate may stimulate platelet formation, and berberine may have an antiheparin action. Thus, berberine may interact with certain drugs that increase the risk of bleeding, and reduce their effectiveness. Some examples include aspirin, anticoagulants ("blood thinners") such as warfarin (Coumadin®) or heparin, anti-platelet drugs such as clopidogrel (Plavix®), and non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen (Motrin®, Advil®) or naproxen (Naprosyn®, Aleve®). However, berberine may be hepatoprotective (liver protective) when administered before toxic doses of acetaminophen.

Berberine may lower blood sugar levels. Caution is advised when using medications that may also lower blood sugar. Patients taking drugs for diabetes by mouth or insulin should be monitored closely by a qualified healthcare professional, including a pharmacist. Medication adjustments may be necessary.

Berberine may decrease total and LDL cholesterol, as well as triglycerides. Caution is advised in patients taking any cholesterol-lowering agents.

There may be additive hypotensive (blood pressure lowering) effects and bradycardia (slowed heart rate) when combining berberine with agents that lower blood pressure. Caution is advised.

Berberine may modulate the expression and function of PGP-170 in hepatoma cells. In theory, berberine may interact with antineoplastic agents.

Berberine and berberine sulfate have anti-inflammatory effects and may interact with COX-2 inhibitors. COX-2 inhibitor drugs include celecoxib (Celebrex®) and rofecoxib (Vioxx®).

Berberine may elevate the blood concentration of cyclosporin A. Caution is advised.

Berberine may interfere with the way the body processes certain drugs using the liver's "cytochrome P450" enzyme system. As a result, the levels of these drugs may be increased in the blood, and may cause increased effects or potentially serious adverse reactions. Patients using any medications should check the package insert, and speak with a qualified healthcare professional, including a pharmacist, about possible interactions.


It is advisable to use caution when taking Julvelin® along with other pharmaceutical medication (oral hypoglycemics or insulin) for diabetes. The combination of Julvelin® and these medications can lower blood-sugar levels to potentially risky levels. If you are already taking diabetes medication, it is extremely important to work with a physician before supplementing with Julvelin® because the physician needs to closely monitor blood-sugar levels. In many instances, your doctor will need to lower the dosage of the pharmaceutical medication you are on.

No other side effects occurred